EPO and diabetes mellitus: Mechanisms potentially leading to anemia development in subjects with diabetes are as follows: erythropoietin deficiency and/or resistance, iron deficiencies (resulting from reduced dietary intake, impaired enteral absorption, blood loss), and proteinuria (with loss of transferrin or erythropoietin) [55].